Table 1.

Parameters estimation from other literature where the means and corresponding credible intervals are shown in the parenthesis

Parameter	Definition	Value	Calculation		Reference
${\displaystyle R_0}$	Basic reproduction number	3.1 (1.9–6.5)			41
${\displaystyle \theta }$	Symptomatic rate	0.792 (0.568–0.815)			42–44
${\displaystyle {\beta }_2}$	Infection rate for symptomatic transmissions	0.62 (0.38–1.3)	${\displaystyle \frac{R_0}{InfectiousPerio{d}_{Severe}}}$		45
${\displaystyle \alpha }$	Reduction of infection rate for asymptomatic transmission	0.55 (0.46–0.62)			46
${\displaystyle {\beta }_1}$	Infection rate for asymptomatic transmissions	0.341 (0.175–0.806)
${\displaystyle {\gamma }_1}$	Clearance rate for asymptomatic/mild cases	0.170 (0.0526–0.287)	${\displaystyle \frac{1}{InfectiousPerio{d}_{Mild}}}$		42 46
						${\displaystyle {\gamma }_2}$	Clearance rate for symptomatic non-severe cases	0.238 (0.143–0.333)	${\displaystyle \frac{1}{InfectiousPerio{d}_{sympt}}}$		47–49
${\displaystyle {\gamma }_3}$	Clearance rate for symptomatic severe cases	0.238 (0.143–0.333)	${\displaystyle \frac{1}{InfectiousPerio{d}_{sympt}}}$		47–49
${\displaystyle \mu }$	Incubation rate	0.202 (0.101–0.364)	${\displaystyle \frac{1}{IncubationTime}}$		50 51
${\displaystyle \delta }$	Severe case fatality rate	0.244 (0.209–0.280)			17 52
${\displaystyle \kappa }$	Increase in rate of progression to severe disease in populations with TB or HIV/AIDS	2.14 (1.1–2.7)			16 17
		Ages 0–64	Ages 65–79	Ages ≥80
${\displaystyle h}$	Rate of progression to severe disease*	0.202 (0.167–0.237)	0.361 (0.286–0.435)	0.471 (0.308–0.634)	53 54
${\displaystyle \kappa h}$	Rate of progression to severe disease in populations with TB and/or HIV/AIDS	0.432 (0.222–0.545)

*Age groups are: 0–59, 60–69, 70+; 0–64, 65–74, 65+, US hospitalisation rate used as a proxy for severe disease progression.

TB, tuberculosis.